2024-03-28, Thu.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Business


Innovative AI software for the detection of pancreatic diseases: first-in-human application successful

Date: 2022-05-17

ACHENMUEHLE, GERMANY-- May 17, 2022 -- Diseases of the pancreas can have serious consequences for patients and are difficult to diagnose. Early detection is crucial for the patient‘s chance of survival. In Europe today, more than 90 percent of patients die of pancreatic cancer within the first five years after diagnosis. The Medi-Globe Group, a leading international MedTech company based in Achenmühle, Bavaria, will, in cooperation with the French Institut Hospitalo-Universitaire (IHU) Strasbourg, develop the world’s first AI software for the detection of diseases of the pancreas in endoscopic ultrasound (EUS) examination. The key technology here is artificial intelligence. As part of large-scale clinical studies prior to market introduction, the AI ​​software has now gone into clinical test with patients, so-called first-in-human applications.

“The new software has the potential to revolutionize the diagnosis of pancreatic diseases and, above all, the diagnosis of pancreatic cancer. That would be a dream for society as a whole and an important milestone in medicine and for medical technology,” says Prof. Dr. Leonardo Sosa Valencia, one of the leading gastroenterologists in the world and a top expert in the field of pancreatic disease detection.

The AI ​​software brings together the clinical experience of the world’s most experienced gastroenterologists. It bundles the knowledge from countless EUS examinations of the pancreas in an algorithm and transforms it into use in endoscopic ultrasound. The expert knowledge is used to train a neural network according to the deep learning method. For the diagnosis, it is crucial to recognize pathologically altered areas in the pancreas at an early stage so that a fine needle biopsy can accurately take tissue samples for further analyses and as basis for therapy decisions.

“With the AI ​​software, in the future we will be able to provide gastroenterologists with a virtual expert and give them the opportunity to significantly improve the diagnostics that determine therapy. Very good results have already been achieved in the first clinical applications. Small lesions were detected, even in complex cases. This gives the treating physicians and, above all, the patients great hope for improvement of patient care in the medium term,” says Dr. Markus Schönberger, Director of Business Development at the Medi-Globe Group.



 to the Top List of News

From Ransomware to Pig Butchering, Visa Report Shows Top Scams Impacting Consumers and Businesses Globally
Lifezone Metals Signs Binding Subscription Agreement for US$50 Million of Unsecured Convertible Debentures with Consortium of Marquee Mining Investors
Kasikorn Securities Selects ICE for Enhanced Portfolio Analytics and Risk Management for Derivatives
Faraday Partnered with SONIX to Create a New Product Featuring Its SONOS eFlash Solution
Merck Invests More than ¢æ 300 Million in New Life Science Production Site in Korea
MUMBAI, INDIA--(Business Wire / Korea Newswire)--India¡¯s leading law firm, Cyril Amarchand Mangaldas (CAM) announced today the establishment of its p
ZAPI GROUP Showcases New Solutions in Material Automation at LogiMAT 2024

 

2024 Thales Data Threat Report Reveals Rise in Ransomware Attacks, as ...
AngloGold Ashanti Releases Preliminary Unaudited Condensed Consolidate...
Visa Foundation Helps To Uplift More Than Four Million SMBs
Andersen Global Bolsters Presence in China
Lifezone Metals Announces Receipt of Licence from Government of Tanzan...
[On the Job] Breaking Boundaries: Exploring Human-Centered Innovation ...
Black & Veatch Offering Insights to High-Level Presidential Trade and ...
Gramercy Funds Management LLC Names Emerging Markets Expert Hamad Almu...
Bureau Veritas Accelerates M&A and Strengthens Its Position in the Ele...
Black Hat Asia 2024 Announces Summit Schedule

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.